Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2003
09/04/2003US20030167515 For increasing yield, disease resistance, insect resistance, herbicide tolerance, drought tolerance, and salt tolerance
09/04/2003US20030167514 For screening/conferring tolerance in plants
09/04/2003US20030167513 Selection and use of isopropylmalate synthase (IPMS) mutants desensitized in L-leucine negative feedback control
09/04/2003US20030167512 Method of determining the presence of a trait in a plant by transfecting a nucleic acid sequence of a donor plant into a different host plant in a positive orientation
09/04/2003US20030167511 Production of p-hydroxybenzoic acid
09/04/2003US20030167510 Hydroperoxide lyase gene from maize and methods of use
09/04/2003US20030167509 Comprises imidazoleglycerol-phosphate dehydratase activity; herbicides; fungicides
09/04/2003US20030167508 Novel plant tryptophan synthase beta subunit
09/04/2003US20030167507 Root-specific, stimulant inducible promoter and its use
09/04/2003US20030167506 Expansin protein and polynucleotides and methods of use
09/04/2003US20030167505 Cell cycle nucleic acids, polypeptides and uses thereof
09/04/2003US20030167504 Maize Rar1-interactor polynucleotides and methods of use
09/04/2003US20030167503 Plant genes encoding pantothenate synthetase
09/04/2003US20030167502 Human monoclonal antibodies to dendritic cells
09/04/2003US20030167501 Antibiotic resistant protein; insertion into plants
09/04/2003US20030167500 Methods and compositions for generating a genetically modified animal using lentiviral vectors
09/04/2003US20030167499 Transgenic mice having decreased fat accumulation; homologous recombination; dietetics
09/04/2003US20030167498 Comprises G-protein gamma subunits (GNG4); transgenic mice; dietetics; drug screening
09/04/2003US20030167497 Methods for defining cell types
09/04/2003US20030167496 Transgenic non-human mammals carrying human pituitary tumor transforming gene (PTTG) sequences
09/04/2003US20030167495 Comprises spinocerebellar ataxias (SCAs) genes; neurodegenerative disorders; homologous recombination; genes
09/04/2003US20030167494 Stretch-activated sodium channel modulators
09/04/2003US20030167493 G-protein coupled receptors (GPCRs); transmembrane proteins; for increased pain threshold; analgesics; drug screening
09/04/2003US20030167490 Gene expression inhibiton/knockout; serpins; fusion proteins
09/04/2003US20030167489 For transgenic mice that produce high levels of humanizing antibodies; immunoglobulins
09/04/2003US20030167488 Mice heterozygous for WFS1 gene as mouse models for depression
09/04/2003US20030167487 Homologous recombination; stem cells; drug screening; platelets
09/04/2003US20030167486 Double transgenic mice overexpressing human beta secretase and human APP-London
09/04/2003US20030167485 Novel G protein-coupled receptor encoding gene and diagnostic uses therefor
09/04/2003US20030167484 Mutant genes; transgenic animals; insertion of stem cell
09/04/2003US20030167483 Analyzing; genetic engineering; transgenic animals, plants
09/04/2003US20030167482 Novel semaphorin Z and gene encoding the same
09/04/2003US20030167481 Methods for amplifying gentic material and uses thereof
09/04/2003US20030167477 Fusion proteins incorporating lysozyme
09/04/2003US20030167474 Superoxide dismutase reduced animal model; Parkinson's disease, sepsis, amyotropic lateral sclerosis; prevent free radical damage
09/04/2003US20030167015 Animal model of atrial fibrillation and screening and therapeutic methods relating thereto
09/04/2003US20030166919 Plant starch compostion
09/04/2003US20030166917 Purification by chromatography, ion exchanging, analyzing
09/04/2003US20030166916 Using porous membrane
09/04/2003US20030166915 Retrovirus from the HIV group and its use
09/04/2003US20030166913 Novel beta-defensins
09/04/2003US20030166912 Novel beta-defensins
09/04/2003US20030166911 Hybrid nucleic acids; genetic engineering
09/04/2003US20030166910 Bone morphogenic protein
09/04/2003US20030166908 Seafood protein; measuring water absorption of fish bladder
09/04/2003US20030166905 Mutant luciferases
09/04/2003US20030166902 Hybrid; process control; genetic engineering
09/04/2003US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents
09/04/2003US20030166898 Myelin oligodendrocyte glycoprotein-like protein (MOGp)
09/04/2003US20030166897 Diagnosis, therapy cancer; transgenic animal
09/04/2003US20030166896 Polynucleotide containing phosphoramidite group
09/04/2003US20030166895 Gene expression; genetic engineering; central nervous system disorders; cardiovascular disorders; glandular disorders; psychological disorders
09/04/2003US20030166893 Measuring, calibrating drug resistance
09/04/2003US20030166891 Novel Bt toxin receptors from lepidopteran insects and methods of use
09/04/2003US20030166890 Antibiotic resistance genes; transgenic animals
09/04/2003US20030166889 Novel human kinases and polynucleotides encoding the same
09/04/2003US20030166883 Genetic engineering; drug screening
09/04/2003US20030166881 Variations, modulation in gene expression; transgenic animals; skin disorders
09/04/2003US20030166879 Adjustable threshold switch
09/04/2003US20030166877 Reducing the immunogenicity of fusion proteins
09/04/2003US20030166876 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3
09/04/2003US20030166875 Fibroblast growth factor homologous factor-2 and methods of use
09/04/2003US20030166873 Endothelial growth factor; measuring binding to monoclonal antibodies; calibration
09/04/2003US20030166872 Grafting antibodies to nucleic acids; anticancer agents, osteoporosis, vision defects, antiinflammatory agents, skin disorders
09/04/2003US20030166871 Grafting; forming libraries; anticancer agents
09/04/2003US20030166869 Chromatography separation using apatite
09/04/2003US20030166865 Loop protein immobilized with polyethylene glycol
09/04/2003US20030166862 Purified mammalian CTLA-8 antigens and related reagents
09/04/2003US20030166861 Human blue-light photoreceptor hCRY2
09/04/2003US20030166859 Controlling cell proliferation, cell differentiation; anticancer agents
09/04/2003US20030166856 A set of open reading frames encoded with the template as the plus strand of the proviral DNA, and located in the region of HIV-1 long terminal repeat, and the genes encode a set of antisense proteins
09/04/2003US20030166854 Allelic variant of human STAT3
09/04/2003US20030166853 Mucin peptide with immunoenhancing properties
09/04/2003US20030166851 Contacting a polypeptide (Transmembrane serin protease 9) with a substrate that is proteolytically cleaved by the polypeptide, adding a test compound, measuring the amount of substrate cleaved in the presence of test compound
09/04/2003US20030166849 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
09/04/2003US20030166847 Novel human leptin receptor gene-related protein
09/04/2003US20030166846 Self-aligning peptides modeled on human elastin and other fibrous proteins
09/04/2003US20030166845 Novel proteins and nucleic acids encoding same
09/04/2003US20030166844 Immunologenic polypeptides; therapy for Streptococcus infections
09/04/2003US20030166842 Mammalian pro-alpha3(V) collagen chain genes
09/04/2003US20030166839 Controlling gene expression
09/04/2003US20030166838 A biologically active peptide at least 85% identical to a peptide: (a) X01ValSerGluX02GlnLeuX03HisX04X05GlyLysX06; (b) fragments containing amino acids 1-9, 1-10, 1-11, 1-12,(c) a salt or (d) N- or C- derivatives
09/04/2003US20030166837 Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof
09/04/2003US20030166832 Methods and compositions for impairing multiplication of HIV-1
09/04/2003US20030166604 Modulating transcription of genes in vascular cells
09/04/2003US20030166603 Using a p53- expressing viral vector as anticarcinogenic agents
09/04/2003US20030166601 Drug delivery of the nucleic acid into a target tissue or cell, comprising a core complex contains a nucleic acid and complex forming agents, fusion with cell membranes with nuclear uptake; polymeric outer shell
09/04/2003US20030166597 Contacting in presence of non-chaotropic salt (sodium chloride); mimetics; nickel-titanium alloy stents
09/04/2003US20030166596 DNA which encodes trehalase and uses thereof
09/04/2003US20030166595 Novel deoxygenases catalyzing cleavage of beta-carotene
09/04/2003US20030166593 Non-viral vesicle vector for cardiac specific gene delivery
09/04/2003US20030166592 For treatment of metabolic disorders (diabetes, obesity)
09/04/2003US20030166591 Testosterone-repressed prostate message-2 (TRPM-2); gene expression inhibition; increased antitumor activity
09/04/2003US20030166589 Method and pharmaceutical composition for the treatment of multiple sclerosis
09/04/2003US20030166588 Splice-region antisense composition and method
09/04/2003US20030166587 Compounds and methods for modulating activation of NF-kB
09/04/2003US20030166569 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
09/04/2003US20030166565 CD antigens; for regulating inflammation; nuclear magnetic resonance; drug screening
09/04/2003US20030166562 Treatment for asthma or allergies
09/04/2003US20030166560 Snail/mollusc polypeptides; anticonvulsant drug screening
1 ... 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 ... 4023